Common questions about Cremor hydrocortisoni PCH (FAQ)
Q: Is it okay to use Cremor hydrocortisoni PCH on my face?
Official regulatory documents describe that topical hydrocortisone is restricted from use on the face unless specifically directed by a healthcare professional. This restriction is due to the face's thinner, more sensitive skin, which carries a higher potential for systemic absorption and local side effects. Regulatory constraints require limited treatment duration in this area.
Q: Can I use other medicated creams or ointments at the same time as this one?
Official guidance describes a requirement to avoid applying other topical products, including medicated creams, at the same time as the hydrocortisone cream. A time separation, such as waiting at least 30 minutes between applications, is generally referenced. This practice is intended to prevent the active medicine from being diluted, which could potentially reduce its effectiveness.
Q: Can I use this cream on sensitive skin areas?
Use on sensitive or thin-skinned areas, such as skin folds, the eyelids, or genital skin, is described in official information as typically restricted. These areas are more susceptible to side effects like skin thinning (atrophy) due to increased absorption. Therefore, application to such sites is subject to strict limitations regarding duration and frequency, requiring medical oversight.
Q: Can I use Cremor hydrocortisoni PCH for diaper rash on a baby?
While low-potency hydrocortisone is indicated for certain inflammatory conditions in the diaper area, regulatory documents include a specific precaution. When the cream is applied to infants, the treated area must not be covered with tight-fitting diapers or plastic pants. These materials function as occlusive dressings, substantially increasing the risk of systemic absorption of the medicine.
Q: Is there a rebound effect if Cremor hydrocortisoni PCH is stopped suddenly?
Official documents note that a collection of symptoms referred to as Topical Steroid Withdrawal Syndrome (TSWS) may occur after ceasing prolonged or frequent use of the medicine. These reactions can include a temporary return or worsening of the original skin condition, which is sometimes described by users as a rebound effect. This phenomenon is a documented safety consideration.
Q: Why is it advised to avoid using this cream near the eyes?
Official labeling includes a specific safety instruction to avoid contact with the eye area. This precaution exists because the use of topical corticosteroids near the eyes is associated with a potential risk of developing serious ophthalmic complications. These complications, which are rare, include cataracts and glaucoma.
Q: What is the typical expectation for symptom relief after starting treatment?
Official product information indicates that an improvement in the condition is generally expected within seven days of starting treatment. If no visible improvement is observed after this period, regulatory instruction suggests that the use of the medicine should be discontinued and the treatment course should be professionally reassessed.
Q: Are there specific ingredients in the cream base that help with absorption?
The extent of the medicine's percutaneous absorption is known to be significantly influenced by the formulation's vehicle, or cream base, and its specific components. Regulatory texts confirm that the cream base itself, being a water-washable emulsion, generally aids in the rapid delivery of the active ingredient to the skin.
Q: Is this cream available over the counter or is a prescription required?
The regulatory status of topical hydrocortisone is dependent on its strength. Lower-potency concentrations, such as the 0.5% or 1% formulations, are typically available for purchase without a prescription (over the counter). Higher concentrations, such as 2.5% cream, generally require a medical prescription.
Q: Does sun exposure affect the use of Cremor hydrocortisoni PCH?
Topical hydrocortisone does not provide any sun protection factor (SPF) and is not formally indicated for application immediately prior to sun exposure. Official guidance states that increased sensitivity to sunlight has been reported as a potential factor in some skin reactions associated with topical steroid use.
Q: Are there different strengths of hydrocortisoni PCH cream?
Yes. Official regulatory documents indicate that hydrocortisone topical creams are broadly available in different strengths. These commonly include 0.5%, 1%, and 2.5% formulations. The specific strength prescribed or purchased dictates its potency classification.
Q: What happens if I forget to use the cream at the usual time?
Official regulatory instruction emphasizes using the medication exactly as directed to maintain consistent treatment. Standard guidance for a missed application indicates that the cream should be applied as soon as it is remembered, and then the patient should return to their regular schedule.
Q: Does using moisturizer affect how Cremor hydrocortisoni PCH works?
Official guidance confirms that applying moisturizers (emollients) at the same time as the cream may affect its action. Applying emollients immediately beforehand can dilute the medication and potentially reduce its effectiveness. For this reason, official practice describes a waiting period of at least 30 minutes between the application of the two products.
Q: Does the cream contain ingredients like alcohol, lanolin, or preservatives?
Yes. Official drug labels list all inactive ingredients (excipients) contained in the formulation. These often include specific preservatives (such as parabens), alcohol components (like cetyl or stearyl alcohol), and lanolin or lanolin-related compounds. The full list of excipients is available for review in the 'Inactive Ingredients' section of the product label.
Q: Is Cremor hydrocortisoni PCH effective for insect bites or stings?
Studies and regulatory indications support the use of hydrocortisone for the symptomatic relief of inflammation and itching in corticosteroid-responsive skin conditions. Furthermore, certain official package leaflets specifically list inflammatory reactions from insect bites as an approved use for this type of cream.
Q: Can I apply makeup or sunscreen over the area treated with the cream?
Official guidance suggests that the cream should be allowed to fully absorb before applying any subsequent topical products, including cosmetics like makeup or sunscreens. A waiting period helps ensure the medicine is not diluted. The cream itself does not provide sun protection.
Q: What should be done if too much cream is accidentally applied?
Regulatory guidance states that if excessive amounts of the cream are used on an occasional basis, it is generally not a concern. However, routine overuse of more than the recommended amount carries a heightened risk of potential systemic side effects.
Q: What research is available on using this cream for anal itching (pruritus ani)?
Hydrocortisone is indicated for the relief of pruritus (itching) associated with corticosteroid-responsive dermatoses. For anal itching (pruritus ani), specific rectal forms of hydrocortisone are formally approved for this condition, reflecting its use as an anti-pruritic agent.
